Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

Auteurs : Cau R, Solinas C, De Silva P, Lambertini M, Agostinetto E, Scartozzi M, Montisci R, Pontone G, Porcu M, Saba L
Jaar : 2022
Journal : Int J Cancer
Volume : 151
Pagina's : 1860-1873

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Auteurs : Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K
Jaar : 2021
Journal : J Clin Invest
Volume : 131

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Auteurs : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C
Jaar : 2021
Journal : Int J Cancer
Volume : 149
Pagina's : 31-41

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.

Auteurs : Pellegrino B, Hlavata Z, Migali C, De Silva P, Aiello M, Willard-Gallo K, Musolino A, Solinas C
Jaar : 2021
Journal : Mol Diagn Ther
Volume : 25
Pagina's : 409-424

A review of immune checkpoint blockade in breast cancer.

Auteurs : Pellegrino B, Tommasi C, Cursio OE, Musolino A, Migliori E, De Silva P, Senevirathne TH, Schena M, Scartozzi M, Farci D, Willard-Gallo K, Solinas C
Jaar : 2021
Journal : Semin Oncol
Volume : 48
Pagina's : 208-225

Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.

Auteurs : Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C
Jaar : 2020
Journal : Transl Oncol
Volume : 13
Pagina's : 410-422

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

Auteurs : De Silva P, Garaud S, Solinas C, de Wind A, Van den Eyden G, Jose V, Gu-Trantien C, Migliori E, Boisson A, Naveaux C, Duvillier H, Craciun L, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Jaar : 2019
Journal : EBioMedicine
Volume : 39
Pagina's : 226-238

LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer.

Auteurs : Solinas C, Migliori E, De Silva P, Willard-Gallo K
Jaar : 2019
Journal : Cancers (Basel)
Volume : 11

Targeting PD-1 in cancer: Biological insights with a focus on breast cancer.

Auteurs : Solinas C, Aiello M, De Silva P, Gu-Trantien C, Migliori E, Willard-Gallo K
Jaar : 2019
Journal : Crit Rev Oncol Hematol
Volume : 142
Pagina's : 35-43

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

Auteurs : Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, Tkint de Roodenbeke D, Willard-Gallo K
Jaar : 2019
Journal : Cancer Lett
Volume : 450
Pagina's : 88-97

Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features.

Auteurs : Porcu M, De Silva P, Solinas C, Battaglia A, Schena M, Scartozzi M, Bron D, Suri JS, Willard-Gallo K, Sangiolo D, Saba L
Jaar : 2019
Journal : Cancers (Basel)
Volume : 11

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Auteurs : Chi VLD, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, Gu-Trantien C, Krayem M, Duvillier H, Lodewyckx JN, Willard-Gallo K, Sibille C, Bron D
Jaar : 2019
Journal : BMC Cancer
Volume : 19
Pagina's : 81

Significance of TIM3 expression in cancer: From biology to the clinic.

Auteurs : Solinas C, De Silva P, Bron D, Willard-Gallo K, Sangiolo D
Jaar : 2019
Journal : Semin Oncol
Volume : 46
Pagina's : 372-379

The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?

Auteurs : Hlavata Z, Solinas C, De Silva P, Porcu M, Saba L, Willard-Gallo K, Scartozzi M
Jaar : 2018
Journal : Target Oncol
Volume : 13(2)
Pagina's : 113-123

Cancer immunotherapy-associated hypophysitis.

Auteurs : Solinas C, Porcu M, De Silva P, Musi M, Aspeslagh S, Scartozzi M, Willard-Gallo K, Mariotti S, Saba L
Jaar : 2018
Journal : Semin Oncol
Volume : 45
Pagina's : 181-186

Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art.

Auteurs : Solinas C, Carbognin L, De Silva P, Criscitiello C, Lambertini M
Jaar : 2017
Journal : Breast
Volume : 35
Pagina's : 142-150

FOXP1 is a key regulator of quiescence in healthy human CD3+ CD4+ T Cells and is constitutively repressed in CD3- CD4+ T cells from patients with lymphoproliferative disorders.

Auteurs : Garaud S, Roufosse F, De Silva P, Gu-Trantien C, Lodewyckx JN, Duvillier H, Dedeurwaerder S, Bizet M, Defrance M, Fuks F, Bex F, Willard-Gallo K
Jaar : 2017
Journal : Eur J Immunol
Volume : 47(1)
Pagina's : 168-179

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy.

Auteurs : Solinas C, Porcu M, Hlavata Z, De Silva P, Puzzoni M, Willard-Gallo K, Scartozzi M, Saba L
Jaar : 2017
Journal : Crit Rev Oncol Hematol
Volume : 120
Pagina's : 13-21

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Auteurs : Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Jaar : 2017
Journal : Front Immunol
Volume : 8
Pagina's : 1412

A Simple and Rapid Protocol to Non-enzymatically Dissociate Fresh Human Tissues for the Analysis of Infiltrating Lymphocytes.

Auteurs : Garaud S, Gu-Trantien C, Lodewyckx JN, Boisson A, De Silva P, Buisseret L, Migliori E, Libin M, Naveaux C, Duvillier H, Willard-Gallo K
Jaar : 2014
Journal : J Vis Exp
Volume : null(94)